Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00750776
What this trial is testing

KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

Who this might be right for
Antipsychotic TreatmentQuality AssuranceMedical Treatment
Psychiatric Centre Rigshospitalet 212
Large-scale testing (Phase 3)Study completedNCT00210769
What this trial is testing

The Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203
Post-approval studies (Phase 4)Study completedNCT00159120
What this trial is testing

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Who this might be right for
SchizophreniaPsychoses
Heinrich-Heine University, Duesseldorf 71
Not applicableStudy completedNCT01376492
What this trial is testing

FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 709
Large-scale testing (Phase 3)Study completedNCT00000371
What this trial is testing

Trial of D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 60
Not applicableStudy completedNCT00389493
What this trial is testing

Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder

Who this might be right for
Obsessive-Compulsive Disorder
New York State Psychiatric Institute 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06754163
What this trial is testing

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Who this might be right for
Obesity and Obesity-related Medical ConditionsPsychiatric Disorders
St Andrew's Healthcare 20
Post-approval studies (Phase 4)Study completedNCT01778244
What this trial is testing

Metformin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
Dyslipidemia
Central South University 162
Not applicableStudy completedNCT00207064
What this trial is testing

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 46
Early research (Phase 1)Study completedNCT05857566
What this trial is testing

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Who this might be right for
Drug-induced Weight Gain
Response Pharmaceuticals 24
Not applicableStudy completedNCT00833456
What this trial is testing

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 106
Large-scale testing (Phase 3)Study completedNCT00216580
What this trial is testing

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 50
Testing effectiveness (Phase 2)UnknownNCT04224441
What this trial is testing

Repurposing Chlorpromazine in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma MultiformeMGMT-Unmethylated Glioblastoma
Marco G Paggi, MD, PhD 41
Not applicableStudy completedNCT02573168
What this trial is testing

Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective Disorder
St. Joseph's Healthcare Hamilton 103
Not applicableStudy completedNCT01269710
What this trial is testing

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+8 more
University of North Carolina, Chapel Hill 4
Not applicableStudy completedNCT00707382
What this trial is testing

Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

Who this might be right for
Schizophrenia
Gesche Jurgens 311
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Not applicableEnded earlyNCT00746252
What this trial is testing

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder

Who this might be right for
Bipolar Disorder
University of Maryland, Baltimore 5
Not applicableLooking for participantsNCT07122531
What this trial is testing

Recovery With Exogenous Ketones and Antipsychotics

Who this might be right for
First Episode Psychosis
Université de Sherbrooke 15
Not applicableStudy completedNCT00999895
What this trial is testing

A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 574
Next Page